We've found
6,982
archived clinical trials in
Endocrine
We've found
6,982
archived clinical trials in
Endocrine
Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
Updated: 5/26/2016
Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
Status: Enrolling
Updated: 5/26/2016
Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
Updated: 5/26/2016
Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
Status: Enrolling
Updated: 5/26/2016
Click here to add this to my saved trials
Timing Estrogen After MenoPaUSe
Updated: 5/31/2016
Time Past Menopause, Duration of Estrogen Deficiency, and Insulin Action
Status: Enrolling
Updated: 5/31/2016
Timing Estrogen After MenoPaUSe
Updated: 5/31/2016
Time Past Menopause, Duration of Estrogen Deficiency, and Insulin Action
Status: Enrolling
Updated: 5/31/2016
Click here to add this to my saved trials
Peds Metabolic Syndrome in Psoriasis
Updated: 6/20/2016
Assessor-Blinded Study of the Metabolic Syndrome and Surrogate Markers of Increased Cardiovascular Risk in Children With Moderate to Severe Psoriasis Compared With Age Matched Population of Children With Warts
Status: Enrolling
Updated: 6/20/2016
Peds Metabolic Syndrome in Psoriasis
Updated: 6/20/2016
Assessor-Blinded Study of the Metabolic Syndrome and Surrogate Markers of Increased Cardiovascular Risk in Children With Moderate to Severe Psoriasis Compared With Age Matched Population of Children With Warts
Status: Enrolling
Updated: 6/20/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Updated: 6/27/2016
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Status: Enrolling
Updated: 6/27/2016
Click here to add this to my saved trials
Male:Female Birth Ratios and Phthalate Levels
Updated: 7/12/2016
Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
Status: Enrolling
Updated: 7/12/2016
Male:Female Birth Ratios and Phthalate Levels
Updated: 7/12/2016
Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Male:Female Birth Ratios and Phthalate Levels
Updated: 7/12/2016
Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
Status: Enrolling
Updated: 7/12/2016
Male:Female Birth Ratios and Phthalate Levels
Updated: 7/12/2016
Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Male:Female Birth Ratios and Phthalate Levels
Updated: 7/12/2016
Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
Status: Enrolling
Updated: 7/12/2016
Male:Female Birth Ratios and Phthalate Levels
Updated: 7/12/2016
Male:Female Birth Ratios and Phthalate Levels Along The Rural Lower Rio Grande Valley (Hidalgo County) and in Baytown, Texas
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
Updated: 7/14/2016
Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
Status: Enrolling
Updated: 7/14/2016
Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
Updated: 7/14/2016
Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
Status: Enrolling
Updated: 7/14/2016
Click here to add this to my saved trials
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Updated: 7/18/2016
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Status: Enrolling
Updated: 7/18/2016
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Updated: 7/18/2016
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Status: Enrolling
Updated: 7/18/2016
Click here to add this to my saved trials
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
Click here to add this to my saved trials
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
Click here to add this to my saved trials
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
Click here to add this to my saved trials
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
Click here to add this to my saved trials
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
Click here to add this to my saved trials
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
Click here to add this to my saved trials
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Updated: 7/19/2016
An Observational Study of the Clinical Characteristics and Disease Progression of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease Phenotype
Status: Enrolling
Updated: 7/19/2016
Click here to add this to my saved trials
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Versartis International Trial in Adults With Long-Acting Growth Hormone
Updated: 7/20/2016
An Open-Label, Dose Finding, International Phase 2 Study With Once Monthly Subcutaneous VRS-317 in Adult Growth Hormone Deficiency (GHD)
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
AZD6244 in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
Updated: 7/20/2016
Phase 2 Study of AZD6244 Hydrogen Sulfate in Iodine-131 Refractory Papillary Thyroid Carcinoma and Papillary Thyroid Carcinoma With Follicular Elements
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
Updated: 7/28/2016
Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
Status: Enrolling
Updated: 7/28/2016
Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
Updated: 7/28/2016
Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop
Status: Enrolling
Updated: 7/28/2016
Click here to add this to my saved trials
Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
Updated: 8/1/2016
Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
Status: Enrolling
Updated: 8/1/2016
Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
Updated: 8/1/2016
Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Continuous Glucose Monitoring and Preterm Infants
Updated: 8/9/2016
NEONATAL HYPOGLYCEMIA and CONTINUOUS GLUCOSE MONITORING: A RANDOMIZED CONTROLLED TRIAL IN PRETERM INFANTS
Status: Enrolling
Updated: 8/9/2016
Continuous Glucose Monitoring and Preterm Infants
Updated: 8/9/2016
NEONATAL HYPOGLYCEMIA and CONTINUOUS GLUCOSE MONITORING: A RANDOMIZED CONTROLLED TRIAL IN PRETERM INFANTS
Status: Enrolling
Updated: 8/9/2016
Click here to add this to my saved trials
Continuous Glucose Monitoring and Preterm Infants
Updated: 8/9/2016
NEONATAL HYPOGLYCEMIA and CONTINUOUS GLUCOSE MONITORING: A RANDOMIZED CONTROLLED TRIAL IN PRETERM INFANTS
Status: Enrolling
Updated: 8/9/2016
Continuous Glucose Monitoring and Preterm Infants
Updated: 8/9/2016
NEONATAL HYPOGLYCEMIA and CONTINUOUS GLUCOSE MONITORING: A RANDOMIZED CONTROLLED TRIAL IN PRETERM INFANTS
Status: Enrolling
Updated: 8/9/2016
Click here to add this to my saved trials
An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly
Updated: 8/10/2016
Extension to a Multi-center, Randomized, Crossover, Open Label, Dose Finding Study to Compare the Safety, Efficacy, and Pharmacokinetics/Pharmacodynamics (PK/PD) Relationship of Multiple Doses of Pasireotide (SOM230) (200, 400, and 600 μg Bid) and Doses of Open Label Sandostatin® (SMS) (100 μg Tid) in Acromegalic Patients
Status: Enrolling
Updated: 8/10/2016
An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly
Updated: 8/10/2016
Extension to a Multi-center, Randomized, Crossover, Open Label, Dose Finding Study to Compare the Safety, Efficacy, and Pharmacokinetics/Pharmacodynamics (PK/PD) Relationship of Multiple Doses of Pasireotide (SOM230) (200, 400, and 600 μg Bid) and Doses of Open Label Sandostatin® (SMS) (100 μg Tid) in Acromegalic Patients
Status: Enrolling
Updated: 8/10/2016
Click here to add this to my saved trials